These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16181325)

  • 21. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum.
    Kanaseki T; Blanchard N; Hammer GE; Gonzalez F; Shastri N
    Immunity; 2006 Nov; 25(5):795-806. PubMed ID: 17088086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
    Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
    Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-translational modifications of naturally processed MHC-binding epitopes.
    Engelhard VH; Altrich-Vanlith M; Ostankovitch M; Zarling AL
    Curr Opin Immunol; 2006 Feb; 18(1):92-7. PubMed ID: 16343885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules.
    Cabrera CM
    Scand J Immunol; 2007 Jun; 65(6):487-93. PubMed ID: 17523940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells.
    Suri A; Walters JJ; Levisetti MG; Gross ML; Unanue ER
    Eur J Immunol; 2006 Mar; 36(3):544-57. PubMed ID: 16479539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformational isomers of a peptide-class II major histocompatibility complex.
    Lovitch SB; Unanue ER
    Immunol Rev; 2005 Oct; 207():293-313. PubMed ID: 16181344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of immunological synapse by membrane-bound and soluble ligands.
    González PA; Carreño LJ; Figueroa CA; Kalergis AM
    Cytokine Growth Factor Rev; 2007; 18(1-2):19-31. PubMed ID: 17344089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing.
    Li P; Gregg JL; Wang N; Zhou D; O'Donnell P; Blum JS; Crotzer VL
    Immunol Rev; 2005 Oct; 207():206-17. PubMed ID: 16181338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A deterministic model for the processing and presentation of bacteria-derived antigenic peptides.
    Janda J; Geginat G
    J Theor Biol; 2008 Feb; 250(3):532-46. PubMed ID: 18061621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coping with loss of perfection in the MHC class I peptide repertoire.
    Blanchard N; Shastri N
    Curr Opin Immunol; 2008 Feb; 20(1):82-8. PubMed ID: 18243675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies?
    Endert Pv
    Eur J Immunol; 2008 Mar; 38(3):609-13. PubMed ID: 18286570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond.
    Lilley BN; Ploegh HL
    Immunol Rev; 2005 Oct; 207():126-44. PubMed ID: 16181332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
    Kao C; Daniels MA; Jameson SC
    Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chicken major histocompatibility complex class II molecules of the B haplotype present self and foreign peptides.
    Cumberbatch JA; Brewer D; Vidavsky I; Sharif S
    Anim Genet; 2006 Aug; 37(4):393-6. PubMed ID: 16879355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes.
    Skokos D; Shakhar G; Varma R; Waite JC; Cameron TO; Lindquist RL; Schwickert T; Nussenzweig MC; Dustin ML
    Nat Immunol; 2007 Aug; 8(8):835-44. PubMed ID: 17632517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57.
    Garbi N; Tanaka S; Momburg F; Hämmerling GJ
    Nat Immunol; 2006 Jan; 7(1):93-102. PubMed ID: 16311600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes.
    Garbi N; Hämmerling G; Tanaka S
    Curr Opin Immunol; 2007 Feb; 19(1):99-105. PubMed ID: 17150345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic quantification of MHC class I-peptide presentation to CD8+ T cells via intracellular cytokine staining.
    Pang KC; Wei JQ; Chen W
    J Immunol Methods; 2006 Apr; 311(1-2):12-8. PubMed ID: 16516224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.